MedPath

Outpatient Laparoscopic Radical Prostatectomy

Recruiting
Conditions
Prostate Cancer
Registration Number
NCT05975775
Lead Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Brief Summary

The purpose of the study is to evaluate the incidence of surgery-related complications between Day 0 and Day 30.

Detailed Description

This is an observational, prospective, open, non-comparative (single arm), bicentric study.

This study is aimed at patients with prostate cancer for whom an ambulatory laparoscopic radical prostatectomy has been validated at a multidisciplinary consultation meeting. The possibility of performing this procedure on an outpatient basis is left to the surgeon's discretion, according to well-defined medical procedure criteria.

This cohort is part of the usual care. The study will observe the incidence and describe the type, number, severity, duration and frequency of procedure-related complications that may arise in the first month post-op of ambulatory Laparoscopic Radical Prostatectomy. For this reason, patient follow-up will stop at 1 month after surgery, during a routine follow-up visit.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
64
Inclusion Criteria
  • Male, age ≥ 18 years;
  • Localized prostate cancer;
  • Validation in a multidisciplinary consultation meeting of curative treatment;
  • Scheduled laparoscopic radical prostatectomy;
  • Patient able to understand the information related to the study, to read the information leaflet and to signify his/her non-opposition or opposition to participating in the study;
  • Membership of a social security scheme;
  • Patient having been informed and having given oral non-opposition.
Exclusion Criteria
  • Surgical emergency;
  • Patient not eligible for ambulatory care;
  • Long-term curative anti-coagulant treatment;
  • Resident more than 100km from the clinic;
  • Home alone the first night;
  • Patient under guardianship, curatorship or deprivation of liberty.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of complications30 days

The primary endpoint was the incidence of procedural complications between Day 0 and Day 30.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinique de la Sauvegarde

🇫🇷

Lyon, France

Clinique de la Sauvegarde
🇫🇷Lyon, France
Arnaud BALDINI, MD
Contact
docteur.baldini@urolyon-ouest.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.